ProPhase Labs PRPH Estimates

OTC PRPH
$0.01 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT
Analyst Estimates

ProPhase Labs, Inc. Revenue Estimates

Periods 16
Next Period Q4 25
Consensus 9.14 M

Analysts expect ProPhase Labs, Inc. to report revenue of 9.14 M for Q4 25, against a range of 8.46 M to 9.81 M. The most recent reported quarter, Q3 25, came in at 883,000.00, a 84.9% miss against the 5.86 M consensus.

Metric Q4 23Q1 24Q2 24Q3 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27
Reported (Actual) 4.35 M3.63 M2.47 M3.15 M1.43 M1.25 M883,000.00--------
High Estimate 11.72 M10.33 M19.11 M3.02 M2.57 M3.57 M6.43 M9.81 M6.03 M5.28 M3.82 M27.61 M11.12 M5.04 M2.86 M
Low Estimate 10.24 M8.68 M16.76 M2.81 M2.20 M3.07 M5.30 M8.46 M5.30 M4.37 M3.55 M24.95 M9.27 M4.63 M2.42 M
Consensus Estimate 10.98 M9.51 M17.94 M2.91 M2.38 M3.32 M5.86 M9.14 M5.66 M4.82 M3.68 M26.28 M10.20 M4.83 M2.64 M
Analyst Estimates

ProPhase Labs, Inc. Earnings Per Share (EPS) Estimates

Periods 16
Next Period Q4 25
Consensus -1.13

Analysts expect ProPhase Labs, Inc. to report earnings per share of -1.13 for Q4 25, against a range of -1.22 to -1.04. The most recent reported quarter, Q3 25, came in at -1.60, a 40.4% miss against the -1.14 consensus.

Metric Q4 23Q1 24Q2 24Q3 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27
Reported (Actual) -5.10-0.70-3.30-3.50-1.30-1.10-1.60--------
High Estimate -2.42-2.45-0.76-2.86-1.63-1.35-1.07-1.043.182.712.503.274.734.544.03
Low Estimate -2.66-2.81-0.90-3.48-1.87-1.47-1.21-1.222.742.272.062.734.053.723.45
Consensus Estimate -2.54-2.63-0.83-3.17-1.75-1.41-1.14-1.132.962.492.283.004.394.133.74

ProPhase Labs, Inc. Estimates API

Pull Wall Street consensus for ProPhase Labs, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=PRPH&mode=revenue&api_key=YOUR_API_KEY